We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+10.66%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$14.1B
AUM Growth
+$1.41B
Cap. Flow
+$185M
Cap. Flow %
1.31%
Top 10 Hldgs %
55.94%
Holding
1,091
New
131
Increased
431
Reduced
407
Closed
118

Sector Composition

Rank Sector Weight
1 Energy 67.18%
2 Technology 4.4%
3 Healthcare 3.48%
4 Financials 3.41%
5 Consumer Discretionary 3.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOLF icon
326
Acushnet Holdings
GOLF
$6.08B
$2.32M 0.02%
35,140
+9,965
+40% +$645K
CNS icon
327
Cohen & Steers
CNS
$4.17B
$2.32M 0.02%
30,120
+4,536
+18% +$324K
REX icon
328
REX American Resources
REX
$1.44B
$2.3M 0.02%
+78,360
New +$1.72M
XENE icon
329
Xenon Pharmaceuticals
XENE
$6.36B
$2.29M 0.02%
53,200
+2,420
+5% +$111K
IMCR icon
330
Immunocore
IMCR
$1.72B
$2.28M 0.02%
35,135
+1,745
+5% +$120K
IDYA icon
331
IDEAYA Biosciences
IDYA
$3.54B
$2.28M 0.02%
51,981
+9,531
+22% +$410K
YMM icon
332
Full Truck Alliance
YMM
$9.66B
$2.23M 0.02%
306,667
+113,695
+59% +$759K
CORT icon
333
Corcept Therapeutics
CORT
$9.78B
$2.21M 0.02%
87,644
+15,284
+21% +$361K
APO icon
334
Apollo Global Management
APO
$71.6B
$2.19M 0.02%
19,495
+2,995
+18% +$316K
FTNT icon
335
Fortinet
FTNT
$112B
$2.19M 0.02%
32,087
-19,834
-38% -$1.32M
KNTK icon
336
Kinetik
KNTK
$3.59B
$2.16M 0.02%
54,136
+17,554
+48% +$602K
ACAD icon
337
Acadia Pharmaceuticals
ACAD
$4.35B
$2.15M 0.02%
116,222
+4,489
+4% +$111K
WTRG icon
338
Essential Utilities
WTRG
$11.2B
$2.14M 0.02%
57,780
+8,748
+18% +$317K
TTWO icon
339
Take-Two Interactive
TTWO
$45.3B
$2.13M 0.02%
14,327
+3,581
+33% +$556K
MLTX icon
340
MoonLake Immunotherapeutics
MLTX
$1.66B
$2.12M 0.02%
42,273
+3,376
+9% +$183K
CALM icon
341
Cal-Maine
CALM
$4.2B
$2.12M 0.02%
36,028
+3,924
+12% +$223K
TTD icon
342
Trade Desk
TTD
$8.41B
$2.09M 0.01%
23,954
-1,938
-7% -$147K
NET icon
343
Cloudflare
NET
$94.3B
$2.06M 0.01%
21,255
-2,550
-11% -$231K
SMMT icon
344
Summit Therapeutics
SMMT
$10.5B
$2.05M 0.01%
494,924
-37,482
-7% -$149K
DUOL icon
345
Duolingo
DUOL
$6.19B
$2.04M 0.01%
9,253
+1,424
+18% +$290K
BSX icon
346
Boston Scientific
BSX
$67.6B
$2.03M 0.01%
29,586
+2,620
+10% +$168K
TSCO icon
347
Tractor Supply
TSCO
$16.7B
$2.02M 0.01%
38,685
+145
+0.4% +$6.93K
DNLI icon
348
Denali Therapeutics
DNLI
$3.74B
$2.01M 0.01%
98,149
+187
+0.2% +$3.51K
PTC icon
349
PTC
PTC
$14.5B
$1.98M 0.01%
10,498
+4,150
+65% +$748K
ARVN icon
350
Arvinas
ARVN
$530M
$1.98M 0.01%
48,023
+12,626
+36% +$552K

Similar funds

ALPS Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, ALPS Advisors held 1,091 positions worth $14.1B, up 11% from $12.7B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

ALPS Advisors's Q1 2024 filing shows 131 new, 431 increased, 407 reduced and 118 closed positions. Its largest new stake was Arcadium Lithium plc: 2,185,225 shares worth $9.42M. The largest sale was Western Midstream Partners, an estimated $67.6M.

By sector, the portfolio is most concentrated in Energy at 67% of assets, up from 66% a quarter earlier, followed by Technology and Healthcare.

  • ALPS Advisors's largest Q1 2024 buy was Arcadium Lithium plc: 2,185,225 shares worth $9.42M.
  • ALPS Advisors added most to Hess Midstream in Q1 2024, an estimated $74.3M increase.
  • ALPS Advisors's biggest Q1 2024 reduction was Western Midstream Partners, cutting an estimated $67.6M.
  • ALPS Advisors fully exited Livent Corporation in Q1 2024, selling an estimated $11.8M.
  • ALPS Advisors's ten largest holdings make up 56% of its $14.1B portfolio in Q1 2024.
  • ALPS Advisors opened 131 new positions and closed 118 in Q1 2024.
  • ALPS Advisors's portfolio value rose 11% quarter-over-quarter to $14.1B.

Based on ALPS Advisors's 13F filing for Q1 2024, filed 14 May 2024.